| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/22/2006 | CN1245977C Liposome anti-neoplastic drugs and uses thereof |
| 03/22/2006 | CN1245966C Use of beta-adrenoceptor antagonists for manufacture of medicament for treatment of disorders of outer retina |
| 03/22/2006 | CN1245963C Medicinal composition including bradycardiac substances and ist use |
| 03/22/2006 | CN1245960C Non-oral preparation having three-layer structure |
| 03/21/2006 | US7015251 Combinations of ceramide and chemotherapeutic agents for inducing tumor cell death |
| 03/21/2006 | US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/21/2006 | US7015232 Stablizer retards cyclization and discoloration of quinapril |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015210 Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 03/21/2006 | US7015195 Treatment of bone disorders with skeletal anabolic drugs |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015190 Administering peptides, mimetics or nucleic acids to interfere with cAMP binding proteins or with DNA so as to derepress cAMP-responsive gene expression; cognition activators; learning enhancement |
| 03/21/2006 | US7014869 Rapid dehydration of proteins |
| 03/21/2006 | US7014863 Additive for an animal feed |
| 03/21/2006 | US7014856 for stimulating or enhancing production of an antibody which recognizes a ganglioside; comprises a ganglioside or oligosaccharide portion conjugated to an immunogenic protein with a carrier and/or vehicle; cancer treatment |
| 03/21/2006 | US7014852 Alkaline phosphatase to induce weight loss or to reduce weight gain |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014846 polyallylamine hydrochloride crosslinked with epichlorohydrin; phosphate removal from gastrointestinal tract; hyperphosphatemia; side effect reduction |
| 03/21/2006 | US7014841 Delivery of antiemetics through an inhalation route |
| 03/21/2006 | US7014840 heating a thin coating to form a vapor then allowing to cool to form a condensation aerosol; kits |
| 03/21/2006 | US7014652 Methods for treating prostatitis |
| 03/21/2006 | CA2443314C Method of imaging cell death in vivo |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/16/2006 | WO2006029142A2 Methods and systems for treating asthma and other respiratory diseases |
| 03/16/2006 | WO2006028836A1 Wound healing |
| 03/16/2006 | WO2006028684A2 Phytases, nucleic acids encoding them and methods of making and using them |
| 03/16/2006 | WO2006028007A1 Remedy for glomerular diseae |
| 03/16/2006 | WO2006027052A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 03/16/2006 | WO2006004633A3 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 03/16/2006 | WO2005118778A3 Method for ex vivo isolating and expanding human cornea stem cells and uses thereof |
| 03/16/2006 | WO2005113003A3 Method for augmenting b cell depletion |
| 03/16/2006 | WO2005110442A3 Peritoneal dialysis solution |
| 03/16/2006 | WO2005086834A3 Methods and compositions for reactivating acetylcholinesterase |
| 03/16/2006 | WO2005070463A3 Compositions comprising (s)-amlodipine malate and an angiotensin receptor blocker and methods of their use |
| 03/16/2006 | WO2005070462A3 Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use |
| 03/16/2006 | WO2005037203A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/16/2006 | WO2005016235A3 Combined use of impdh inhibitors with toll-like receptor agonists |
| 03/16/2006 | US20060059579 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058392 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase |
| 03/16/2006 | US20060058380 Novel aminobenzophenone compounds |
| 03/16/2006 | US20060058344 Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 03/16/2006 | US20060058333 Analgesic compositions containing buprenorphine |
| 03/16/2006 | US20060058332 sublingual administration of N-cyclopropylmethyl-7 alpha -[1-(S)-hydroxy-1,2,2-trimethylpropyl]6,14-endoethano-6,7,8,14-tetrahydro-nororipavine, in combination with naloxone, naltrexone or nalmefene; synergistic mixtures for the treatment of pain in humans or animals |
| 03/16/2006 | US20060058331 Abuse resistant opioid dosage form |
| 03/16/2006 | US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058300 Intermediates of bupropion metabolites synthesis |
| 03/16/2006 | US20060058274 Use of an aldosterone receptor antagonist to improve cognitive function |
| 03/16/2006 | US20060058273 A combination of a cephalosporin. prednisolone and a carrier to treat milk-producing animals having clinical mastis of the mammary gland; increased antiinflammatory efficiency without the immunosuppressive side effects; bovine mastitis; veterninary medicine |
| 03/16/2006 | US20060058267 Pharmaceutical compositions comprising a NOS inhibitor |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057254 Zinc-rich foods having effect of preventing diabetes |
| 03/16/2006 | US20060057252 Composition containing calcium pantothenate and vitamin |
| 03/16/2006 | US20060057234 Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra |
| 03/16/2006 | US20060057219 Method for preparing a polymer micelle pharmaceutical preparation containing drug for injection |
| 03/16/2006 | US20060057202 Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them |
| 03/16/2006 | US20060057185 Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| 03/16/2006 | US20060057171 Solitonium and textile having solitonium for weight reduction |
| 03/16/2006 | US20060057154 Compositions for inducing of immunotolerance |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057074 Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| 03/16/2006 | DE102004038328A1 Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New uses of 2-phenyl-substituted derivatives imidazotriazinone |
| 03/16/2006 | CA2578988A1 Phytases, nucleic acids encoding them and methods of making and using them |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1634618A1 Method for identifying compounds that increase bone mineral density |
| 03/15/2006 | EP1634607A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 03/15/2006 | EP1634605A2 Treatment of dyslipidemia in a patient having type 2 diabetes |
| 03/15/2006 | EP1634601A2 Dietary supplement comprising soyabean, mushroom and mung bean |
| 03/15/2006 | EP1634597A1 Compositions comprising dextromethorphan and quinidine or quinine for the treatment of emotional lability |
| 03/15/2006 | EP1634589A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 03/15/2006 | EP1634585A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 03/15/2006 | EP1633872A2 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/15/2006 | EP1633734A2 Mucin synthesis inhibitors |
| 03/15/2006 | EP1633402A2 Pharmaceutical composition |
| 03/15/2006 | EP1633401A1 A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 03/15/2006 | EP1633400A2 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines |
| 03/15/2006 | EP1633394A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 03/15/2006 | EP1633385A1 Compositions and methods for treatment of rosacea |
| 03/15/2006 | EP1633377A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/15/2006 | EP1633376A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 03/15/2006 | EP1633370A2 Combination of an aldosterone receptor antagonist and an anti-obesity agent |
| 03/15/2006 | EP1633351A1 5-substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor rup25 for the treatment of dyslipidemia and related diseases |
| 03/15/2006 | EP1633341A2 Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis |
| 03/15/2006 | EP1633339A1 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 03/15/2006 | EP1633338A1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 03/15/2006 | EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 03/15/2006 | EP1451577A4 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1390039B1 Use of estrogen compounds to increase libido in women |
| 03/15/2006 | EP1331937B1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |